Inventor · disambiguated record
Guangrong Zheng
Also filed as: ZHENG GUANGRONG
21 granted patents·15 pending applications·33 citations·filing 2002–2025
91Inventor score
Top patents by PatentIndex Score
36 records- 0192US10668030B2Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuseUNIV KENTUCKY RES FOUND·Filed 2017·Granted Jun 2, 2020·10 cites·4 claims
- 0289US10071087B2Compositions and methods for selectively depleting senescent cellsBIOVENTURES LLC·Filed 2015·Granted Sep 11, 2018·6 cites·10 claims
- 0384US9309547B2Methods for making tocoflexols and analogues thereofUNIV ARKANSAS·Filed 2013·Granted Apr 12, 2016·5 cites·13 claims
- 0481US11999676B2Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuseUNIV KENTUCKY RES FOUND·Filed 2020·Granted Jun 4, 2024·1 cites·12 claims
- 0581US10807977B2Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereofBIOVENTURES LLC·Filed 2017·Granted Oct 20, 2020·2 cites·19 claims
- 0678US10758524B2Compositions and methods for selectively depleting senescent cellsBIOVENTURES LLC·Filed 2018·Granted Sep 1, 2020·1 cites·11 claims
- 0771US8299253B2Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsCROOKS PETER·Filed 2006·Granted Oct 30, 2012·1 cites·10 claims
- 0871US2022315523A1Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant AbuseUNIV KENTUCKY RES FOUND·Filed 2022·Application pending·0 cites
- 0968US8846937B2Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsCROOKS PETER·Filed 2007·Granted Sep 30, 2014·1 cites·12 claims
- 1068US8178678B2Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsCROOKS PETER·Filed 2007·Granted May 15, 2012·1 cites·10 claims
- 1167US6703406B22,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storageUNIV KENTUCKY RES FOUND·Filed 2002·Granted Mar 9, 2004·5 cites·9 claims
- 1259US2010179186A1USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDSUNIV KENTUCKY RES FOUND·Filed 2009·Application pending·0 cites
- 1358US11319316B2Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereofBIOVENTURES LLC·Filed 2020·Granted May 3, 2022·0 cites·21 claims
- 1457US2020237688A1Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuseUNIV KENTUCKY RES FOUND·Filed 2020·Application pending·0 cites
- 1556US8940774B2Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine ReceptorsUNIV KENTUCKY RES FOUND·Filed 2013·Granted Jan 27, 2015·0 cites·11 claims
- 1656US2016031840A11,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine CompoundsUNIV KENTUCKY RES FOUND·Filed 2014·Application pending·0 cites
- 1755US2023330237A1Modulators of nuclear receptor subfamily 4 group a member 1 (nr4a1) and uses thereofUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1854US8703803B2Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsUNIV KENTUCKY RES FOUND·Filed 2012·Granted Apr 22, 2014·0 cites·9 claims
- 1953US9550753B2Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsUNIV KENTUCKY RES FOUND·Filed 2014·Granted Jan 24, 2017·0 cites·10 claims
- 2053US8653275B2Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptorsCROOKS PETER·Filed 2007·Granted Feb 18, 2014·0 cites·9 claims
- 2153US2025375441A1Oncolytic therapy with a dual hdac3 and hdac8 targeting agentUNIV FLORIDA·Filed 2025·Application pending·0 cites
- 2251US2023181746A1Benzoylhydrazide-derived hdac degraders as therapeutics for treating cancer and other human diseasesUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2350US9649301B2Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptorsUNIV KENTUCKY RES FOUND·Filed 2015·Granted May 16, 2017·0 cites·42 claims
- 2450US2024398764A1Methods of treating diseases associated with senescent cell accumulationUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 2550US2014080859A1Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine ReceptorsUNIV KENTUCKY RES FOUND·Filed 2013·Application pending·0 cites
- 2650US2025057963A1Discovery of piperlongumine as a novel e3 ligase ligandUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 2750US2017226072A11,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine CompoundsUNIV KENTUCKY RES FOUND·Filed 2017·Application pending·0 cites
- 2848US12118414B2BCL-2 proteins degraders for cancer treatmentBIOVENTURES LLC·Filed 2019·Granted Oct 15, 2024·0 cites·20 claims
- 2948US2025154141A1Bcl-xl/bcl-2 dual degraders for treatment of cancersUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 3048US2013231366A1Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and AidsUNIV KENTUCKY RES FOUND·Filed 2013·Application pending·0 cites
- 3146US2019054097A1Compositions targeting senescent cells and the uses thereofBIOVENTURES LLC·Filed 2018·Application pending·0 cites
- 3244US9540327B2Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptorsCROOKS PETER·Filed 2007·Granted Jan 10, 2017·0 cites·16 claims
- 3343US12441722B2Therapeutic agents and methods of treatmentUNIV FLORIDA·Filed 2021·Granted Oct 14, 2025·0 cites·22 claims
- 3443US12084423B2Piperlongumine analogues and uses thereofBIOVENTURES LLC·Filed 2018·Granted Sep 10, 2024·0 cites·17 claims
- 3539US7368443B22,6-disubstituted piperidines and piperazine compoundsUNIV KENTUCKY RES FOUND·Filed 2004·Granted May 6, 2008·0 cites·19 claims
- 3639US2022169628A1Therapeutic agents and methods of treatmentUNIV FLORIDA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →